Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2018

17.02.2018 | Original Article

The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999–2014

verfasst von: Keiju S. K. Kontula, Kirsi Skogberg, Jukka Ollgren, Asko Järvinen, Outi Lyytikäinen

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Few studies covering all patient groups and specialties are available regarding the outcome of nosocomial bloodstream infections (BSI). We analyzed the role of patient characteristics and causative pathogens of nosocomial BSIs reported by the hospitals participating in national surveillance in Finland during 1999–2014, in terms of outcome, with particular interest in those leading to death within 2 days (i.e. early death). National nosocomial BSI surveillance was laboratory-based and hospital-wide. Data on nosocomial BSIs was collected by infection control nurses, and dates of death were obtained from the national population registry with linkage to national identity codes. A total of 17,767 nosocomial BSIs were identified; 557 BSIs (3%) were fatal within 2 days and 1150 (6%) within 1 week. The 1-month case fatality was 14% (2460 BSIs), and 23% of the deaths occurred within 2 days and 47% within 1 week. The patients who died early were older than those who survived > 28 days, and their BSIs were more often related to intensive care. Gram-positive bacteria caused over half of the BSIs of patients who survived, whereas gram-negative bacteria, especially Pseudomonas aeruginosa, caused more often BSIs of patients who died early, and fungi BSIs of patients who died within 1 week. A significant portion of patients with nosocomial BSIs died early, which underlines the importance of rapid recognition of BSI. Hospital-wide surveillance data of causative pathogens can be utilized when composing recommendations for empiric antimicrobial treatment in collaboration with clinicians, as well as when promoting infection prevention.
Literatur
1.
Zurück zum Zitat Rodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E et al (2010) Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 16:1408–1413CrossRefPubMed Rodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E et al (2010) Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 16:1408–1413CrossRefPubMed
2.
Zurück zum Zitat Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61–69CrossRefPubMed Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61–69CrossRefPubMed
3.
Zurück zum Zitat Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB (2012) The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 12:85CrossRefPubMedPubMedCentral Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB (2012) The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 12:85CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317CrossRefPubMed Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317CrossRefPubMed
5.
Zurück zum Zitat McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS (2005) Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165:308–313CrossRefPubMed McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS (2005) Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165:308–313CrossRefPubMed
6.
Zurück zum Zitat Mitt P, Adamson V, Lõivukene K, Lang K, Telling K, Päro K et al (2009) Epidemiology of nosocomial bloodstream infections in Estonia. J Hosp Infect 71:365–370CrossRefPubMed Mitt P, Adamson V, Lõivukene K, Lang K, Telling K, Päro K et al (2009) Epidemiology of nosocomial bloodstream infections in Estonia. J Hosp Infect 71:365–370CrossRefPubMed
7.
Zurück zum Zitat Vrijens F, Hulstaert F, Van de Sande S, Devriese S, Morales I, Parmentier Y (2010) Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect 75:158–162CrossRefPubMed Vrijens F, Hulstaert F, Van de Sande S, Devriese S, Morales I, Parmentier Y (2010) Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect 75:158–162CrossRefPubMed
8.
Zurück zum Zitat Lyytikäinen O, Klemets P, Ruutu P, Kaijalainen T, Rantala M, Ollgren J et al (2007) Defining the population-based burden of nosocomial pneumococcal bacteremia. Arch Intern Med 167:1635–1640CrossRefPubMed Lyytikäinen O, Klemets P, Ruutu P, Kaijalainen T, Rantala M, Ollgren J et al (2007) Defining the population-based burden of nosocomial pneumococcal bacteremia. Arch Intern Med 167:1635–1640CrossRefPubMed
9.
Zurück zum Zitat Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C et al (2010) Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 48:1726–1731CrossRefPubMedPubMedCentral Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C et al (2010) Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 48:1726–1731CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J (2017) Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis 65:644–652CrossRefPubMed Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J (2017) Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis 65:644–652CrossRefPubMed
11.
Zurück zum Zitat Åttman E, Aittoniemi J, Sinisalo M, Vuento R, Lyytikäinen O, Kärki T et al (2015) Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital. Leuk Lymphoma 56:3370–3377CrossRefPubMed Åttman E, Aittoniemi J, Sinisalo M, Vuento R, Lyytikäinen O, Kärki T et al (2015) Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital. Leuk Lymphoma 56:3370–3377CrossRefPubMed
12.
Zurück zum Zitat Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32:992–997CrossRefPubMed Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32:992–997CrossRefPubMed
13.
Zurück zum Zitat Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I et al (2011) Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 11:30–38CrossRefPubMed Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I et al (2011) Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 11:30–38CrossRefPubMed
14.
Zurück zum Zitat Pedersen G, Schønheyder HC (1997) Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis 29:169–173CrossRefPubMed Pedersen G, Schønheyder HC (1997) Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis 29:169–173CrossRefPubMed
15.
Zurück zum Zitat Laupland KB, Svenson LW, Gregson DB, Church DL (2011) Long-term mortality associated with community-onset bloodstream infection. Infection 39:405–410CrossRefPubMed Laupland KB, Svenson LW, Gregson DB, Church DL (2011) Long-term mortality associated with community-onset bloodstream infection. Infection 39:405–410CrossRefPubMed
16.
Zurück zum Zitat Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P (2012) Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect 18:E170–E176CrossRefPubMed Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P (2012) Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect 18:E170–E176CrossRefPubMed
17.
Zurück zum Zitat Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P et al (2002) Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 35:e14–e19CrossRefPubMed Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P et al (2002) Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 35:e14–e19CrossRefPubMed
18.
Zurück zum Zitat Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed
19.
Zurück zum Zitat Kontula KS, Skogberg K, Ollgren J, Järvinen A, Lyytikäinen O (2016) Early deaths in bloodstream infections: a population-based case series. Infect Dis (Lond) 48:379–385CrossRef Kontula KS, Skogberg K, Ollgren J, Järvinen A, Lyytikäinen O (2016) Early deaths in bloodstream infections: a population-based case series. Infect Dis (Lond) 48:379–385CrossRef
20.
Zurück zum Zitat Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244CrossRefPubMed Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244CrossRefPubMed
21.
Zurück zum Zitat Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41:3655–3660CrossRefPubMedPubMedCentral Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41:3655–3660CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Hoenigl M, Wagner J, Raggam RB, Prueller F, Prattes J, Eigl S et al (2014) Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria. PLoS One 9:e104702CrossRefPubMedPubMedCentral Hoenigl M, Wagner J, Raggam RB, Prueller F, Prattes J, Eigl S et al (2014) Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria. PLoS One 9:e104702CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH (2005) Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49:1306–1311CrossRefPubMedPubMedCentral Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH (2005) Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49:1306–1311CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386CrossRefPubMed Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386CrossRefPubMed
25.
Zurück zum Zitat Poikonen E, Lyytikäinen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P et al (2010) Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 10:312CrossRefPubMedPubMedCentral Poikonen E, Lyytikäinen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P et al (2010) Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 10:312CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Vallés J, Calbo E, Anoro E, Fontanals D, Xercavins M, Espejo E et al (2008) Bloodstream infections in adults: importance of healthcare-associated infections. J Inf Secur 56:27–34 Vallés J, Calbo E, Anoro E, Fontanals D, Xercavins M, Espejo E et al (2008) Bloodstream infections in adults: importance of healthcare-associated infections. J Inf Secur 56:27–34
Metadaten
Titel
The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999–2014
verfasst von
Keiju S. K. Kontula
Kirsi Skogberg
Jukka Ollgren
Asko Järvinen
Outi Lyytikäinen
Publikationsdatum
17.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3211-0

Weitere Artikel der Ausgabe 5/2018

European Journal of Clinical Microbiology & Infectious Diseases 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.